Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 12, 2004, Pages 4222-4227

  Bhoumik, Anindita ^a   Jones, Nic ^b   Ronai, Ze'Ev ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANISOMYCIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME BINDING; GENE MUTATION; GENETIC TRANSCRIPTION; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; APOPTOSIS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOPLASM; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MELANOMA; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PEPTIDES; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 1642447684     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0400195101     Document Type: Article

References (42)

1. Pawlik, T. M. & Sondak, V. K. (2003) Crit. Rev. Oncol. Hematol. 45, 245-264.
2. Soengas, M. S. & Lowe, S. W. (2003) Oncogene 22, 3138-3151.
3. Ivanov, V. N., Bhoumik, A. & Ronai, Z. (2003) Oncogene. 22, 3152-3161.
4. Ivanov, V. N., Bhoumik, A., Krasilnikov, M., Ras, R., Owen-Schaub, L. B., Levy, D., Horvath, C. M. & Ronai, Z. (2001) Mol. Cell 7, 517-528.
5. Ivanov, V. N., Lopez, B. P., Maulit, G., Sato, T. A., Sassoon, D. & Ronai, Z. (2003) Mol. Cell. Biol. 23, 3623-3635.
6. Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) Nature 409, 207-211.
7. Zhang, X. D., Franco, A. V., Nguyen, T., Gray, C. P. & Hersey, P. (2000) J. Immunol. 164, 3961-3970.
8. Ivanov, V. N., Kehrl, J. H. & Ronai, Z. (2000) Oncogene 19, 933-942.
9. Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., et al. (2002) Nature 417, 949-954.
10. Smalley, K. S. M. (2003) Int. J. Cancer. 104, 527-532.
11. Bohm, M., Moellmann, G., Cheng, E., Alvarez-Franco, M., Wagner, S., Sassone-Corsi, P. & Halaban, R. (1995) Cell Growth Differ. 6, 291-302.
12. De Cesare, D., Jacquot, S., Hanauer, A. & Sassone-Corsi, P. (1998) Proc. Natl. Acad. Sci. USA 95, 12202-12207.
13. McGill, G. G., Horstmann, M., Widlund, H. R., Du. J., Motyckova, G., Nishimura, E. K., Lin, Y. L., Ramaswamy, S., Avery, W., Ding, H. F., et al (2002) Cell 109, 707-718.
14. Wilund, H. R., Hortsmann, M. A., Price, E. R., Cui, J., Lessnick, S. L., Wu, M., He, X. & Fisher, D. E. (2002) J. Cell. Biol. 158, 1079-1087.
15. McCawley, L. J., LI, S., Wattenberg, E. V. & Hudson, L. G. (1999) J. Biol. Chem. 274, 4347-4353.
16. Woods, D., Cherwinski, H., Venetsanakos, E., Bhat, A., Gysin, S., Humbert, M., Bray, P. F., Saylor, V. L. & McMahon, M. (2001) Mol. Cell. Biol. 21, 3192-31205.
17. Krasilnikov, M., Ivanov, V. N., Dong, J. & Ronai, Z. (2003) Oncogene, 22, 4092-4101.
18. Ouwens, D. M., de Ruiter, N. D., van der Zon, G. C., Carter, A. P., Schouten, J., van der Burgt, C., Kooistra, K., Bos, J. L., Maassen, J. A. & van Dam, H. (2002) EMBO J. 21, 3782-3793.
19. Gutpa, S., Campbell, D., Derijard, B. & Davis, R. J. (1995) Science 267, 389-393.
20. Kerppola, T. K. & Curran, T. (1993) Mol. Cell. Biol. 13, 5479-5489.
21. Falvo, J. V., Parekh, B. S., Lin, C. H., Fraenkel, E. & Maniatis, T. (2000) Mol. Cell. Biol. 20, 4814-4824.
22. Kaszubska, W., Hooft van Huijsduijnen, R., Ghersa, P., DeRAemy-Schenk, A. M., Chen, B. P., Hai, T., DeLamarter, J. F. & Whelan, J. (1993) Mol. Cell. Biol. 13, 7180-7190.
23. Kim, S. J., Wagner, S., Liu, F., O'Reilly, M. A., Robbins, P. D. & Green, M. R. (1992) Nature 358, 331-334.
24. Ivanov, V. N. & Ronai, Z. (1999) J. Biol. Chem. 274, 14079-14089.
25. Ronai, Z., Yang., Y. M., Fuchs, S. Y., Adler, V., Sardana, M. & Herlyn, M. (1998) Oncogene 16, 523-531.
26. Bhoumik, A., Ivanov, V. & Ronai, Z. (2001) Clin. Cancer Res. 2, 331-342.
27. Bhoumik, A., Huang, T. G., Ivanov, V., Gangi, L., Qiao, R. F., Woo, S. L., Chen, S. H. & Ronai, Z. (2002) J. Clin. Invest. 110, 643-650.
28. Berger, A., Harriet, K., Ning, L., Eric, K., Halaban, R., Ronai, Z. & Rimm, D. L. (2003) Cancer Res., 63, 8103-8107.
29. Habelhah, H., Shah, K., Huang, L., Burlingame, A. L., Shokat, K. M. & Ronai, Z. (2001) J. Biol. Chem. 276, 18090-18095.
30. Brummelkamp, T. R., Bernards, R. & Agami, R. (2002) Cancer Cell. 2, 243-247.
31. He, K. L. & Ting, A. T. (2002) Mol. Cell. Biol. 17, 6034-6045.
32. Didier, C., Broday, L., Bhoumik, A., Israeli, S., Takahashi, S., Nakayama, K., Thomas, S.M., Turner, C.E., Henderson, S., Sabe, H. & Ronai, Z. (2003) Mol. Cell. Biol. 15, 5331-5345.
33. Fuchs, S. Y., Dolan, L., Davis, R. J. & Ronai, Z. (1996) Oncogene 13, 1531-1535.
34. Owen-Schaub, L. B., van Golen, K. L., Hill, L. L. & Price, J. E. (1998) J. Exp. Med. 188, 1717-1723.
35. Rahmani, M., Peron, P., Weitzman, J., Bakiri, L., Lardeux, B. & Bernuau, D. (2001) Oncogene 20, 5132-5142.
36. Lamb, J. A., Ventura, J. J., Hess, P., Flavell, R. A. & Davis, R. J. (2003) Mol. Cell. 11, 1479-1489.
37. Bossy-wetzel, E., Bakiri, L. & Yaniv, M. (1997) EMBO J. 16, 1695-1709.
38. Behrens, A., Sibilia, M. & Wagner, E. F. (1999) Nat. Genet. 3, 326-329.
39. Fuchs, S. Y. & Ronai, Z. (1999) Mol. Cell. Biol. 5, 3289-3298.
40. Weiss, C., Schneider, S., Wagner, E. F., Zhang, X., Seto, E. & Bohmann, D. (2003) EMBO J. 22, 3686-3695.
41. Weitzman, J. B., Fiette, L., Matsuo, K. & Yaniv, M. (2000) Mol. Cell. 6, 1109-1119.
42. Gallo, A., Cuozzo, C., Esposito, I., Maggiolini, M., Bonofiglio, D., Vivacqua, A., Garramone, M., Weiss, C., Bohmann, D. & Musti, A.M. (2002) Oncogene 21, 6434-6445.